Search research articles
Contact Us
Filters
Showing results (141-150 of 334) with videos related to
Page
of 34
Sort By:
Radiation Oncology (London, England)
|
June 13, 2014
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Karel Decaestecker, Gert De Meerleer, Bieke Lambert, et al.
Current Oncology Reports
|
March 29, 2019
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer
Gargi Kothari, Piet Ost, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2018
Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma
Nora Sundahl, Katrien De Wolf, Vibeke Kruse, et al.
Clinical Genitourinary Cancer
|
September 8, 2018
Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium
Valérie Fonteyne, Elke Rammant, Piet Ost, et al.
European Urology
|
December 4, 2018
Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates
Aurélie De Bruycker, Elise De Bleser, Karel Decaestecker, et al.
Molecular Imaging and Biology
|
April 12, 2022
Impact of <sup>18</sup>F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : <sup>18</sup>F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
Kathia De Man, Sarah Piron, Nick Van Laeken, et al.
BMC Urology
|
February 5, 2021
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
Samuel W D Merriel, Daniel Moon, Phil Dundee, et al.
European Urology Oncology
|
October 25, 2022
Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers
Mai Anh Huynh, Chad Tang, Shankar Siva, et al.
European Urology Focus
|
September 26, 2022
Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER Trial
Valérie Fonteyne, Charles Van Praet, Piet Ost, et al.
Current Opinion in Oncology
|
January 30, 2019
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
Pauline De Bruyn, Dirk Van Gestel, Piet Ost, et al.
Page
of 34
Search research articles
Search
Showing results (141-150 of 334) with videos related to
Sort By:
Page
of 34
Radiation Oncology (London, England)
|
June 13, 2014
Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
Karel Decaestecker, Gert De Meerleer, Bieke Lambert, et al.
Current Oncology Reports
|
March 29, 2019
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer
Gargi Kothari, Piet Ost, Patrick Cheung, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 28, 2018
Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma
Nora Sundahl, Katrien De Wolf, Vibeke Kruse, et al.
Clinical Genitourinary Cancer
|
September 8, 2018
Evaluating the Current Place of Radiotherapy as Treatment Option for Patients With Muscle Invasive Bladder Cancer in Belgium
Valérie Fonteyne, Elke Rammant, Piet Ost, et al.
European Urology
|
December 4, 2018
Nodal Oligorecurrent Prostate Cancer: Anatomic Pattern of Possible Treatment Failure in Relation to Elective Surgical and Radiotherapy Treatment Templates
Aurélie De Bruycker, Elise De Bleser, Karel Decaestecker, et al.
Molecular Imaging and Biology
|
April 12, 2022
Impact of <sup>18</sup>F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging : <sup>18</sup>F-PSMA-11 PET/CT and Impact on Prostate Cancer Management
Kathia De Man, Sarah Piron, Nick Van Laeken, et al.
BMC Urology
|
February 5, 2021
A modified Delphi study to develop a practical guide for selecting patients with prostate cancer for active surveillance
Samuel W D Merriel, Daniel Moon, Phil Dundee, et al.
European Urology Oncology
|
October 25, 2022
Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers
Mai Anh Huynh, Chad Tang, Shankar Siva, et al.
European Urology Focus
|
September 26, 2022
Evaluating the Impact of Prostate Only Versus Pelvic Radiotherapy for Pathological Node-positive Prostate Cancer: First Results from the Multicenter Phase 3 PROPER Trial
Valérie Fonteyne, Charles Van Praet, Piet Ost, et al.
Current Opinion in Oncology
|
January 30, 2019
Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?
Pauline De Bruyn, Dirk Van Gestel, Piet Ost, et al.
Page
of 34